The FDA has cleared the investigational new drug application for CHM 2101, a novel CDH17-targeted CAR T-cell therapy, for the treatment of patients with gastrointestinal cancers.
Rama Mallampalli, MD | Ohio State College of Medicine osu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from osu.edu Daily Mail and Mail on Sunday newspapers.